Call it a case of good chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is entering into a new partnership with Pfizer’s Ignite program to support development of the biotech’s unique cell immunotherapies.
France-based clinical research company Aixial Group is consolidating clinical data from one of its business units into Medidata’s digital platform, according to a Sept. 3 release.
After escaping a clinical hold several years back, Dyne Therapeutics has revealed new phase 1/2 data for its Duchenne muscular dystrophy (DMD) therapy DYNE-251. The readout notes several serious treatment-emergent adverse events (TEAEs), including acute kidney injury.
America’s job market rebounded in November, adding 227,000 workers in a solid recovery from the previous month, when the effects of strikes and hurricanes had sharply diminished employers’ payrolls
U.S. stocks rose to records after data suggested the job market remains solid enough to keep the economy going, but not so strong that it raises immediate worries about inflation
BofA says visit to Giga Texas confirms that FSD progress supports a 2025 robotaxi launch, and Optimus is ‘real’
There are signs that demand for cruises keep growing, with record bookings post-Thanksgiving
ProKidney has stopped one of a pair of phase 3 trials for its cell therapy for kidney disease after deciding it wasn’t essential for securing FDA approval.
Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme disease vaccine, but that hasn’t stopped the companies collecting more positive data in the meantime.
A study from Abbott found that employing its cardiac valve repair implant during earlier phases of heart failure—when a patient’s leaky mitral valve is still considered to be functional—could lead to fewer related hospitalizations while improving health status and quality of life.
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s disease
GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease
Innovent links cytokine fusion protein to responses in colorectal cancer
FDA scraps adcomm for Applied’s rare disease drug ahead of November decision
Inflammation-focused Upstream set to join growing trickle of biotech IPOs
NIH establishes pandemic preparedness network, plans up to $100M in yearly funding for work on new treatments and vaccines
Novo Nordisk bets $600M biobucks on NanoVation’s ability to take genetic medicines beyond the liver
Capricor sells Europe rights to DMD therapy for $35M as FDA application approaches
Lumps of coal for Wall Street money managers — again
Stock market will find it hard to rally unless the dollar and bonds calm down
